Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Prospective Study: The Impact of Step Count Measured by Smartwatches on Treatment Response in Non-Metastatic HER2-Negative Breast Cancer Patients Receiving Neoadjuvant Therapy

NCT07162675 is registered in ClinicalTrials.gov with Ankara Etlik City Hospital as lead sponsor.

NCT NCT07162675
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07162675 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Prospective Study: The Impact of Step Count Measured by Smartwatches on Treatment Response in Non-Metastatic HER2-Negative Breast Cancer Patients Receiving Neoadjuvant Therapy
Lead sponsor
Ankara Etlik City Hospital
Phase
Observational
Overall status
Recruiting
Start date
September 8, 2025
Completion date
February 15, 2027
Enrollment
82 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer females, breast neoplasm malignant female, exercise, sleep quality, smartwatches, wearable technology